tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Aydin Huseynov, 53 are a BUY (81.54%), 12 are a HOLD (18.46%).
Analyst Aydin Huseynov, currently employed at LADENBURG, carries an average stock price target met ratio of 46.67% that have a potential upside of 77.07% achieved within 351 days. Previously, Aydin Huseynov worked at BENCHMARK.
Aydin Huseynov’s has documented 118 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on ATHE, Alterity Therapeutics Ltd at 16-Jun-2026.
Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for NRBO (NEUROBO PHARMACEUTICALS) at 12/13/2022. The price target of $6 was fulfilled within 15 days with a profit of $7.2 (54.55%) receiving and performance score of 36.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$2
$1.97 (6566.67%)
$2
3 years 10 months 22 days ago
(15-Nov-2022)
3/4 (75%)
$-0.38 (-15.97%)
53
Buy
$8
$7.97 (26566.67%)
4 years 1 months 8 days ago
(29-Aug-2022)
0/1 (0%)
$4.17 (108.88%)
Buy
$140
$139.97 (466566.66%)
6 years 4 months 26 days ago
(11-May-2020)
0/2 (0%)
$3.2 (2.34%)
Buy
$340
$339.95 (679900.00%)
$240
9 years 6 months 8 days ago
(29-Mar-2017)
3/3 (100%)
$110.33 (71.65%)
163
Which stock is Aydin Huseynov most bullish on?
What Year was the first public recommendation made by Aydin Huseynov?
